Jing Wenxian, Liu Juan, Wu Shanshan, Li Xuerui, Liu Yongsheng
State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.
Front Microbiol. 2021 Feb 4;12:604079. doi: 10.3389/fmicb.2021.604079. eCollection 2021.
Although it has been reported that deletion of the response regulator, CpxR, in the CpxRA system confers sensitivity to aminoglycosides (AGAs) and β-lactams in serovar Typhimurium, the regulatory effects of CpxA on multidrug resistance (MDR) are yet to be fully investigated in this organism. Here, to explore the role of CpxA in MDR, various mutants including a null mutant (JSΔ), a site-directed mutant (JSΔ ) and an internal in-frame deletion mutant (JSΔ ) of the serovar Typhimurium strain JS, were constructed. It was revealed that and deletion mutants have opposing roles in the regulation of resistance to AGAs and β-lactams. Amikacin and cefuroxime can activate the CpxRA system, which results in increased resistance of the wild-type compared with the deletion mutant. All the mutations significantly increased resistance to AGAs and β-lactams due to CpxRA system activation the phosphorylation of CpxR. Moreover, AckA-Pta-dependent activation of CpxR increased the antibiotic resistance of deletion mutants. Further research revealed that the AcrAB-TolC conferred resistance to some AGAs and β-lactams but does not influence the regulation of resistance by CpxRA against these antibiotics. The detection of candidate MDR-related CpxR regulons revealed that the mRNA expression levels of , , , , , and were upregulated and that of was downregulated in various mutants. Furthermore, the expression levels of and mRNAs were downregulated only in JSΔ . These results suggested that mutations contribute to AGAs and β-lactams resistance, which is dependent on CpxR.
尽管已有报道称,鼠伤寒血清型中CpxRA系统的应答调节因子CpxR缺失会使其对氨基糖苷类(AGAs)和β-内酰胺类药物敏感,但CpxA对该生物体多药耐药性(MDR)的调节作用尚未得到充分研究。在此,为了探究CpxA在MDR中的作用,构建了鼠伤寒血清型菌株JS的各种突变体,包括一个缺失突变体(JSΔ)、一个定点突变体(JSΔ)和一个读码框内缺失突变体(JSΔ)。结果显示,[此处原文缺失具体突变体名称]缺失突变体在AGAs和β-内酰胺类药物抗性调节中具有相反作用。阿米卡星和头孢呋辛可激活CpxRA系统,与[此处原文缺失具体突变体名称]缺失突变体相比,这导致野生型的抗性增加。所有[此处原文缺失具体突变体名称]突变均因CpxRA系统激活(CpxR的磷酸化)而显著增加了对AGAs和β-内酰胺类药物的抗性。此外,AckA-Pta依赖性的CpxR激活增加了[此处原文缺失具体突变体名称]缺失突变体的抗生素抗性。进一步研究表明,AcrAB-TolC赋予了对某些AGAs和β-内酰胺类药物的抗性,但不影响CpxRA对这些抗生素的抗性调节。对候选MDR相关CpxR调控子的检测显示,在各种[此处原文缺失具体突变体名称]突变体中,[此处原文缺失具体基因名称]、[此处原文缺失具体基因名称]、[此处原文缺失具体基因名称]、[此处原文缺失具体基因名称]、[此处原文缺失具体基因名称]和[此处原文缺失具体基因名称]的mRNA表达水平上调,而[此处原文缺失具体基因名称]的mRNA表达水平下调。此外,[此处原文缺失具体基因名称]和[此处原文缺失具体基因名称]mRNA的表达水平仅在JSΔ中下调。这些结果表明,[此处原文缺失具体突变体名称]突变导致对AGAs和β-内酰胺类药物的抗性,这依赖于CpxR。